# Veterflix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/veterflix

- Industry: Software
- Headquarters: Seoul, South Korea
- Website: www.3dmedivision.com
- Total disclosed funding: $2.2M
- Latest round: Series A (Jul 15, 2016)
- Investors on record: 4

## About

Based in South Korea, 3D Medivision Inc. specializes in advanced medical education technology, providing innovative 3D visualization solutions for medical professionals to enhance training and patient care.3D Medivision Inc. was founded in 2011 and is headquartered in Seoul, South Korea. The company focuses on medical education technology, offering solutions for medical training. Ki-jin Kim serves as the CEO. The company recently raised KRW 2,232.698 mn in funding from investors including HB Investment and KNOTUS, bringing the total amount raised to KRW 2,232.698 mn and valuing the company at KRW 39,374.169 mn. In 2021, Leading Ace Capital acquired a 6.71% minority stake in 3D Medivision Inc. from BNH Investment.3D Medivision specializes in advanced medical education technology, focusing on innovative 3D visualization tools designed for medical professionals. Their products enable users to simulate complex medical procedures and anatomical studies, serving medical schools and healthcare institutions. The company’s offerings are particularly geared towards surgical training, allowing users to engage in realistic practice scenarios without using live patients. Key markets include North America, Europe, and parts of Asia, with continuous updates to products based on user feedback.In 2022, 3D Medivision reported revenue of KRW 972,654.9 and an EBITDA of KRW -1,367,299. The company's revenue structure is primarily based on subscription models and direct sales to healthcare institutions, focusing on B2B transactions that provide access to their suite of 3D educational tools through annual subscription agreements tailored to institutional needs.3D Medivision plans to expand its product line by launching new 3D educational tools designed to further enhance medical training, with specific release dates to be determined. The company is targeting expansion into additional markets in Asia and Europe by 2024. Recent funding will support these initiatives, allowing the company to invest in product development and market penetration strategies.

## Funding rounds

- Series A, Jul 15, 2016, $2.2M — KB Investment, WOORI Venture Partners
- Seed, Feb 1, 2016 — BNH Investment, Korea Tech Incubator for Startup

## Investors

- BNH Investment (https://capitalatlas.ai/funds/bnh-investment) — Seed
- Korea Tech Incubator for Startup — Seed
- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Series A
- WOORI Venture Partners (https://capitalatlas.ai/funds/woori-venture-partners) — Series A